Your session is about to expire
← Back to Search
Stimulant Medication for ADHD
Study Summary
This trialwill examine if stimulants improve executive functioning in college students with ADHD but not those without, to better understand efficacy and prevent misuse.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have been diagnosed with ADHD and experience five or more symptoms of inattention according to the DSM-5 Symptom Checklist.If you are a healthy participant, you must not have been diagnosed with ADHD and should have very few symptoms of inattention and hyperactivity/impulsivity.You have had a concussion in the last 6 months, have had two or more concussions in your life, or have had a previous traumatic brain injury.You have a medical condition that makes taking stimulant medication risky for you.People without ADHD will be excluded if they have ever used stimulant drugs without a prescription.If you have ADHD and take prescription stimulant medication, you will be asked not to take it the day before and the day of any study visits. If you are not okay with not taking your medication, you will not be able to participate.You are currently taking other medications for mental health or attention-related issues, like SSRIs, SNRIs, sedatives, or Strattera.You are taking any other prescription medications that could cause problems when taken with Adderall, such as drugs for the nervous system or blood pressure, or antihistamines.You drink a lot of caffeine every day, like more than six cups of coffee or other high-caffeine drinks.You are not allowed to use nicotine products such as cigarettes, e-cigarettes, chewing tobacco, nicotine gum, or patches regularly.
- Group 1: Stimulant Medication
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 5 Other Conditions - This treatment demonstrated efficacy for 5 other conditions.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What primary conditions are stimulant medications most commonly prescribed to address?
"Stimulant Medication can provide relief to those with diseases, chronic pain, and Attention Deficit Hyperactivity Disorder."
Are individuals under twenty years of age admissible to this experimentation?
"This trial is open to individuals between 18 and 30 years of age. For those younger or older than this range, there are 113 trials for minors and 56 pertaining to seniors."
Are stimulant medications authorized by the FDA?
"Our team at Power assigned a 2 out of 3 to Stimulant Medication, due to the existing safety data but lack thereof regarding efficacy in Phase 2 trials."
Who can become a participant in this trial?
"To be considered for participation, applicants must have a documented history of stimulant abuse and fall between the ages 18-30. A total of 40 people are being recruited to this trial."
Are there any other research initiatives exploring the use of Stimulant Medication?
"Currently, 11 clinical studies are investigating Stimulant Medication with 2 trials within Phase 3. Although the majority are situated in Lexington, Kentucky, a total of 15 locations across America have begun their own respective investigations."
Is recruitment still underway for this investigation?
"Unfortunately, this trial is no longer actively searching for participants. Initially posted on February 11th 2020 and later edited on July 22nd 2020, the study has fulfilled its recruitment quota. However, if you are looking for other trials related to stimulant abuse or medication, there are currently 187 studies recruiting patients and 11 clinical trials actively accepting applicants."
To what extent is this trial being populated by volunteers?
"This investigation is no longer accepting candidates. Initially posted on the 11th of February 2020, and updated for the last time on July 22nd 2020, it has since closed to additional participants. For those searching for alternate studies, there are currently 187 trials concerning stimulant abuse actively recruiting individuals and a further 11 studies exploring Stimulant Medication looking for volunteers."
What are the main aims of this experiment?
"This medical trial, evaluated over a three week period, seeks to observe the alterations in Spatial Span (SS) due to Adderall treatment compared with placebo. The secondary objectives include administering surveys for Depression, Anxiety and Stress Scale-Modified (DASS-M), Pittsburgh Sleep Quality Index-Modified (PSQI-M), and Side Effects Rating Scale - Modified assessing emotional experiences of depression, anxiety, stress levels as well as sleep functioning such as subjective quality, latency and efficiency from "yesterday" until bedtime."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How responsive is this trial?
Average response time
- < 1 Day
Most responsive sites:
- University of Wyoming: < 24 hours
Typically responds via
Share this study with friends
Copy Link
Messenger